233. ウォルフラム症候群 Wolfram syndrome Clinical trials / Disease details

臨床試験数 : 11 / 薬物数 : 17 - (DrugBank : 8) / 標的遺伝子数 : 12 - 標的パスウェイ数 : 41

6 trials found

diseases per page:

Showing 1 to 6 of 6 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT04940572 (ClinicalTrials.gov)	November 26, 2021	11/5/2021	Efficacy Study of Daily Administration of VPA in Patients Affected by Wolfram Syndrome	AUDIOWOLF: A Phase II, Open-label, Efficacy Study of Daily Administration of Sodium Valproatein Pati ...	Wolfram Syndrome	Drug: Depakine	Centre d'Etude des Cellules Souches	Genethon	Recruiting	13 Years	N/A	All	23	Phase 2	France
2	EUCTR2017-001215-37-PL (EUCTR)	13/02/2020	10/10/2019	Clinical Trial of a Treatment to Slow Disease Progression Compared to Usual Standard of Care in Chil ...	A pivotal, international, randomised, double-blind, efficacy and safety trial of sodium valporate in ...	Wolfram syndrome;Therapeutic area: Diseases [C] - Nervous System Diseases [C10]	Trade Name: Sodium valproate 200 mg gastro-resistant tablets	University of Birmingham	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	70	Phase 2	France;Poland;United Kingdom
3	NCT03717909 (ClinicalTrials.gov)	December 28, 2018	11/10/2018	Efficacy and Safety Trial of Sodium Valproate, in Paediatric and Adult Patients With Wolfram Syndrom ...	A Pivotal, International, Randomised, Double-blind, Efficacy and Safety Trial of Sodium Valproate, i ...	Wolfram Syndrome	Drug: Sodium Valproate 200Mg E/C Tablet;Drug: Sodium Valproate matched placebo	University of Birmingham	NULL	Recruiting	5 Years	N/A	All	70	Phase 2	France;Poland;Spain;United Kingdom
4	EUCTR2017-001215-37-GB (EUCTR)	19/03/2018	21/06/2018	Clinical Trial of a Treatment to Slow Disease Progression Compared to Usual Standard of Care in Chil ...	A pivotal, international, randomised, double-blind, efficacy and safety trial of sodium valporate in ...	Wolfram syndrome;Therapeutic area: Diseases [C] - Nervous System Diseases [C10]	Trade Name: Sodium ValproateWockhardt 200mg Gastro-Resistant tablets Product Name: Sodium ValproateWo ...	University of Birmingham	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	70	Human pharmacology (Phase 1): no Therapeutic exploratory (Phase 2): yes Therapeutic confirmatory - ( ...	France;Poland;Spain;United Kingdom
5	EUCTR2017-001215-37-FR (EUCTR)		03/02/2020	Clinical Trial of a Treatment to Slow Disease Progression Compared to Usual Standard of Care in Chil ...	A pivotal, international, randomised, double-blind, efficacy and safety trial of sodium valporate in ...	Wolfram syndrome;Therapeutic area: Diseases [C] - Nervous System Diseases [C10]	Trade Name: Sodium ValproateWockhardt 200mg Gastro-Resistant tablets Product Name: Sodium ValproateWo ...	University of Birmingham	NULL	NA			Female: yes Male: yes	70	Phase 2	France;Spain;Poland;United Kingdom
6	EUCTR2020-004594-43-FR (EUCTR)		11/03/2021	AUDIOWOLF: A phase II, open-label, efficacy study of daily administration of sodium valproatein pati ...	AUDIOWOLF: A phase II, open-label, efficacy study of daily administration of sodium valproatein pati ...	Wolfram syndrome MedDRA version: 20.0;Level: PT;Classification code 10078338;Term: Wolfram syndrome; ...	Trade Name: DEPAKINE CHRONO® 500 mg Product Name: DEPAKINE CHRONO 500 mg	CECS/I-Stem	NULL	NA			Female: yes Male: yes	23	Phase 2	France

First Previous1Next Last